Liu, Dongjing
Zusman, Benjamin E.
Shaffer, John R.
Li, Yunqi
Arockiaraj, Annie I.
Liu, Shuwei
Weeks, Daniel E.
Desai, Shashvat M.
Kochanek, Patrick M.
Puccio, Ava M.
Okonkwo, David O.
Conley, Yvette P.
Jha, Ruchira M. http://orcid.org/0000-0002-3047-7649
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (K23NS101036, R01NS115815, 1R01NS087978-01)
National Institute of Nursing Research (R00 NR013176, R01NR013342)
National Institutes of Health (P50 NS30318)
Chuck Noll Foundation
Barrow Neurological Foundation
Article History
Received: 10 August 2021
Accepted: 14 December 2021
First Online: 13 January 2022
Conflicts of Interest
: RMJ is a paid consultant and is on advisory boards for Biogen and ASTRALĀ (Antagonizing SUR1-TRPM4 to Reduce the Progression of Intracerebral Hematoma and Edema Surrounding Lesions clinical trial). The other authors declare no conflicts of interest.
: The University of Pittsburgh Institutional Review Board approved this study.